Montfort Hospital, commonly shortened to Montfort in both languages, is a teaching hospital affiliated with the University of Ottawa. It delivers short-term primary and secondary health care in both French and English.

There are 289 beds in Hopital Montfort.

During the past decade, Hopital Montfort conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Montfort" #1 sponsor was "Hopital Montfort" with 2 trials, followed by "Ottawa Hospital Research Institute" with 2 trials sponsored, "Assurex Health Inc." with 1 trials sponsored, "McMaster University" with 1 trials sponsored and "Sunnybrook Health Sciences Centre" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Montfort" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "AFP Innovation Fund" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator and "Arch Biopartners Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Montfort" are "COVID-19" (2 trials), "Covid19" (2 trials), "Colonic Polyps" (1 trials), "Colorectal Cancer" (1 trials) and "Corona Virus Infection" (1 trials). Many other conditions were trialed in "Hopital Montfort" in a lesser frequency.

Most popular intervention types in "Hopital Montfort" are "Drug" (3 trials), "Device" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-SARS-CoV-2 mAb" (1 trials), "Artesunate" (1 trials), "Cognitive Behavior Group Therapy" (1 trials), "Dexamethasone" (1 trials) and "Enhanced-GeneSight Psychotropic (E-GEN)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Montfort" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Montfort". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital Montfort, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Montfort, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".